2026. Evaluation of the inhibitory effect of 2,5-Dimethyl-Celecoxib on tamoxifen-sensitive and -resistant human breast cancer cells (MCF-7). Clinical Medicine and Pharmacology. 3, 1 (Jan. 2026). DOI:https://doi.org/10.70731/sh45n436.